Barclays’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,169
Closed -$44K 4619
2025
Q1
$44K Sell
6,169
-2,703
-30% -$19.3K ﹤0.01% 3922
2024
Q4
$196K Sell
8,872
-384
-4% -$8.48K ﹤0.01% 3532
2024
Q3
$185K Buy
9,256
+6,129
+196% +$123K ﹤0.01% 3526
2024
Q2
$54K Sell
3,127
-11,830
-79% -$204K ﹤0.01% 3647
2024
Q1
$623K Sell
14,957
-2,696
-15% -$112K ﹤0.01% 2712
2023
Q4
$443K Buy
17,653
+4,915
+39% +$123K ﹤0.01% 3070
2023
Q3
$417K Buy
12,738
+9,809
+335% +$321K ﹤0.01% 2655
2023
Q2
$170K Buy
+2,929
New +$170K ﹤0.01% 3167
2022
Q3
Sell
-3
Closed 4843
2022
Q2
$0 Sell
3
-257
-99% ﹤0.01% 4943
2022
Q1
$14K Hold
260
﹤0.01% 4420
2021
Q4
$18K Sell
260
-70
-21% -$4.85K ﹤0.01% 3115
2021
Q3
$52K Sell
330
-217
-40% -$34.2K ﹤0.01% 3378
2021
Q2
$107K Sell
547
-161
-23% -$31.5K ﹤0.01% 3120
2021
Q1
$183K Buy
708
+275
+64% +$71.1K ﹤0.01% 3151
2020
Q4
$83K Buy
+433
New +$83K ﹤0.01% 3028
2020
Q3
Sell
-5
Closed -$1K 3939
2020
Q2
$1K Buy
+5
New +$1K ﹤0.01% 3747
2020
Q1
Sell
-585
Closed -$188K 3950
2019
Q4
$188K Buy
585
+390
+200% +$125K ﹤0.01% 3204
2019
Q3
$74K Buy
+195
New +$74K ﹤0.01% 3549
2019
Q2
Sell
-8
Closed -$4K 4462
2019
Q1
$4K Buy
+8
New +$4K ﹤0.01% 4104
2018
Q4
Sell
-11
Closed -$3K 4429
2018
Q3
$3K Buy
11
+6
+120% +$1.64K ﹤0.01% 4150
2018
Q2
$3K Hold
5
﹤0.01% 4068
2018
Q1
$22K Buy
+5
New +$22K ﹤0.01% 3819